Related Experiment Videos
Alpha-1-antitrypsin in liver disease
1Biochemistry Department, Royal Melbourne Hospital, Parkville, Victoria, Australia.
Annals of Clinical Biochemistry
|March 1, 1989
Summary
Liver disease typically results in normal or increased alpha-1-antitrypsin (AAT) levels, not low levels. Low AAT in liver patients may indicate an abnormal AAT phenotype requiring further investigation.
Area of Science:
- Hepatology
- Clinical Biochemistry
Background:
- Low alpha-1-antitrypsin (AAT) levels are recognized indicators of liver disease.
- The liver synthesizes AAT, prompting an investigation into whether liver disease can directly cause reduced AAT levels.
Purpose of the Study:
- To determine the relationship between liver disease and alpha-1-antitrypsin (AAT) levels.
- To investigate if liver dysfunction leads to decreased plasma AAT concentrations.
Main Methods:
- Plasma AAT levels were measured in 100 patients diagnosed with various liver diseases.
- Patient data included diagnoses such as hepatitis, cirrhosis, jaundice, and liver failure.
- AAT levels were categorized as increased, normal, or decreased based on established reference ranges.
Main Results:
- The majority of patients (70%) exhibited normal AAT levels (1.5–3.1 g/L).
- A significant portion (28%) showed increased AAT levels (>3.1 g/L).
- Only two patients (2%) presented with decreased AAT levels (<1.5 g/L), both identified with the PiMZ phenotype. No significant correlation was found between standard liver function tests and AAT levels.
Conclusions:
- Liver disease commonly presents with normal or elevated alpha-1-antitrypsin (AAT) levels.
- Significantly low AAT levels in patients with liver disease are rare.
- The presence of low AAT in liver disease patients warrants investigation into potential abnormal AAT phenotypes, such as PiMZ.